BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19101098)

  • 1. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management.
    Kennedy AP; Phillips KA; Epstein DH; Reamer DA; Schmittner J; Preston KL
    Drug Alcohol Depend; 2013 Jun; 130(1-3):77-84. PubMed ID: 23195924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- versus dual-drug target: effects in a brief abstinence incentive procedure.
    Correia CJ; Dallery J; Katz EC; Silverman K; Bigelow G; Stitzer ML
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):302-8. PubMed ID: 14599264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients.
    Ghitza UE; Epstein DH; Preston KL
    Addict Behav; 2008 Apr; 33(4):593-604. PubMed ID: 18068905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
    Chutuape MA; Silverman K; Stitzer ML
    J Subst Abuse Treat; 1999 Jan; 16(1):23-30. PubMed ID: 9888118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.
    Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Psychopharmacology (Berl); 1999 Sep; 146(2):128-38. PubMed ID: 10525747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.
    Umbricht A; DeFulio A; Winstanley EL; Tompkins DA; Peirce J; Mintzer MZ; Strain EC; Bigelow GE
    Drug Alcohol Depend; 2014 Jul; 140():92-100. PubMed ID: 24814607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin.
    Ghitza UE; Epstein DH; Schmittner J; Vahabzadeh M; Lin JL; Preston KL
    J Consult Clin Psychol; 2007 Oct; 75(5):765-74. PubMed ID: 17907858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
    Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.
    Jones HE; Haug N; Silverman K; Stitzer M; Svikis D
    Drug Alcohol Depend; 2001 Feb; 61(3):297-306. PubMed ID: 11164694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients.
    Donlin WD; Knealing TW; Needham M; Wong CJ; Silverman K
    J Appl Behav Anal; 2008; 41(4):499-516. PubMed ID: 19192855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study.
    Dunn KE; Sigmon SC; Thomas CS; Heil SH; Higgins ST
    J Appl Behav Anal; 2008; 41(4):527-38. PubMed ID: 19192857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users.
    Preston KL; Ghitza UE; Schmittner JP; Schroeder JR; Epstein DH
    J Appl Behav Anal; 2008; 41(4):551-63. PubMed ID: 19192859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.
    Katz EC; Chutuape MA; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2002 May; 10(2):136-43. PubMed ID: 12022799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.